Charles M. Farber

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

Carla Casulo, Michelle Byrtek, Keith Dawson et al. · Journal of Clinical Oncology · 2015 · 818 citations · Full text

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

Jonathan W. Friedberg, Michael D. Taylor, James R. Cerhan et al. · Journal of Clinical Oncology · 2009 · 291 citations · Full text

Detection and Identification of Plant Pathogens on Maize Kernels with a Hand-Held Raman Spectrometer

Charles M. Farber, Dmitry Kurouski · Analytical Chemistry · 2018 · 140 citations

Plant Analysis, Food Forensics, Botany +23

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Complementarity of Raman and Infrared Spectroscopy for Structural Characterization of Plant Epicuticular Waxes

Charles M. Farber, Jingbai Li, Elizabeth Hager et al. · ACS Omega · 2019 · 105 citations · Full text

Corresponding Raman, Structural Characterization, Flavoromics +16